SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chaubey Alka – ‘4’ for 2/15/24 re: Bionano Genomics, Inc.

On:  Tuesday, 3/5/24, at 5:48pm ET   ·   For:  2/15/24   ·   As:  Officer   ·   Accession #:  1415889-24-6811   ·   File #:  1-38613

Previous ‘4’:  ‘4’ on 9/20/23 for 9/18/23   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/24  Chaubey Alka                      4          Officer     1:5K   Bionano Genomics, Inc.            SEC Connect

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      6K 
                Securities by an Insider --                                      
                form4-03052024_100328.xml/5.8                                    




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — form4-03052024_100328.xml/5.8
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  2/15/24
Issuer:
Issuer CIK:  1411690
Issuer Name:  Bionano Genomics, Inc.
Issuer Trading Symbol:  BNGO
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1821605
Owner Name:  Chaubey Alka
Reporting Owner Address:
Owner Street 1:  C/O BIONANO GENOMICS, INC.
Owner Street 2:  9540 TOWNE CENTRE DRIVE, SUITE 100
Owner City:  SAN DIEGO
Owner State:  CA
Owner ZIP Code:  92121
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  CHIEF MEDICAL OFFICER
Other Text:
Aff 10b5 One:  0
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  2/15/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  F
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  1,081
Footnote ID:  F1
Transaction Price Per Share:
Value:  1.27
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  31,487
Footnote ID:  F2
Footnote ID:  F3
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Nature of Ownership:
Value:
Derivative Table:
Footnotes:
Footnote - F1The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
Footnote - F2On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock.
Footnote - F3Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.
Owner Signature:
Signature Name:  /s/ Jonathan V. Dixon, Attorney-in-Fact
Signature Date:  3/5/24


Top
Filing Submission 0001415889-24-006811   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 2:13:00.1am ET